Factor Associated to Bacterial Vaginosis in Non-pregnant Women of North Indian Population,

¹Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India

²Department of Obstetrics and Gynaecology, CHC, Sarai Akil, Allahabad, India

³Department of Pharmacy, Banasthali University, Banasthali, Rajasthan, India

Corresponding Author:

Hari Om Singh
Department of Molecular Virology
National AIDS Research Institute (ICMR), GOI, 73 'G' Block
MIDC, Bhosari, Pune-411026, India
Tel: +91-020-27331200 (1244--O)
Fax: + 91-020-272121071
E-mail: hsingh@nariindia.org or hariomsgpgims@gmail.com

Received date: June 26, 2015; Accepted date: August 30, 2015; Published date: September 06, 2015

Citation: Om SH, Amita S, Dhole TN, Nain S (2015) Factor Associated to Bacterial Vaginosis in Non-pregnant Women of North Indian Population. J Biotechnol Biomater 5:195. doi:10.4172/2155-952X.1000195

Copyright: © 2015 Om SH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Biotechnology & Biomaterials

Abstract

Bacterial vaginosis is currently the most prevalent cause of vaginal infection and vaginal discharge among the sexually active women. Bacterial vaginosis is a complex microbiological disease. Therefore, we aimed to determine the association of risk factors for bacterial vaginosis patients. In the prospective study, we enrolled a total of 300 nonpregnant women. One hundred and twenty six women were positive for bacterial vaginosis, confirmed by Amsel's criteria and Nugent's scoring. One hundred and seventy four women were unrelated control. Frequency of intrauterine contraceptive device differed significantly between bacterial vaginosis and healthy individuals (29.4% versus 17.2%, p=0.017; OR=1.70). Individuals with a sexual transmitted disease in partners was conferred significantly higher risk for bacterial vaginosis (p=0.001, OR=8.28). However, use of contraception, vaginal douching, and use of condom did not modulate the risk of bacterial vaginosis. Individuals with the use of intrauterine contraceptive device and presence of sexual transmitted disease in partners conferred a higher risk for bacterial vaginosis.

Keywords

Bacterial vaginosis; Genitourinary disease; Intrauterine contraceptive device; Risk factor; Sexual transmitted infection; Vaginal infections

Abbreviations

BV: Bacterial Vaginosis; STI: Sexually Transmitted Infections; IUCD: Intrauterine Contraceptive Device; ORs: Odds ratios; 95% CI: 95% Confidence Interval

Introduction

Bacterial vaginosis (BV) is one of the most common vaginal infections worldwide. It is characterized by vaginal flora changes. BV has been associated with a variety of adverse health outcomes, including preterm delivery, intrauterine infection [1], pelvic inflammatory disease (PID) [2], other gynecological complications [3] and reproductive outcomes, including endometriosis [4]. In sub- Saharan Africa, the prevalence of BV is very high, ranging from 30–51% in community based studies [5,6]. A high prevalence has also been reported among African-American women with estimates of up to 50% in populationbased surveys [7]. The prevalence of bacterial vaginosis in India varies from 32.8% and 13.33% among women in Delhi and Gujarat respectively [8,9]. Studies have revealed that bacterial vaginosis can be intermittent [10] that up to 35% of women with bacterial vaginosis lack symptoms, and the prevalence can exceeds up to 25% in certain population subgroups [11,12].

Preventive strategies target the risk factors or behaviors for disease. The etiology and pathogenesis of bacterial vaginosis remains poorly understood [13], although sexual activity and vaginal hygiene practices have been associated with BV [14-18]. Reproductive hormones are also thought to play a role in the regulation of vaginal flora [19,20]. Previous studies have identified a number of risk factors and behaviours associated with BV, including the number of lifetime male sexual partners, recent partner change, lower age of first intercourse, having a female sexual partner in the past 12 months, being unemployed, being unmarried, working as a sex worker, smoking, and failure to use condoms or less frequent use of condoms, more frequent episodes of receptive oral sex, use of multiple partner at time, spermicide use, more frequent vaginal intercourse, sexually transmitted diseases (STD), use of intrauterine contraceptive device (IUCD), race and vaginal douching ([21-25]. Numerous studies have investigated the association of risk factors and bacterial vaginosis but there are inconsistencies in results [20,24,26-29]. However, many previous studies have been reported, but lack of reporting on association of bacterial vaginosis with its risk factors in Indian populations. Therefore, the present study was carried out to determine the potential risk factors associated with bacterial vaginosis in a North Indian population.

Materials and Methods

Subjects

A total of 300 sexually active non pregnant women between period of July 2007 to July 2009, attending OPD of obstetrics and gynecology, CHC, Sarai Akil, Allahabad, Uttar Pradesh, India, with complaints of vaginal discharge were recruited. One hundred twenty six women of a reproductive age group (15-25 year) with complaints of white discharge with or without other symptoms as itching were screened for bacterial vaginosis, confirmed by Amsel's clinical criteria and interpretation of Gram staining is done by Nugent's Scoring (Table 1). One hundred seventy four bacterial vaginosis negative (healthy unrelated females) was also recruited who accompanied patients seeking treatments for minor ailments at OPD of Obstetrics and Gynecology, CHC, Sarai Akil, Allahabad, Uttar Pradesh. All of them underwent screening for Amsel's clinical criteria and Nugent's scoring. Females negative for both the criteria were included as controls in the study. The study was approved by the local ethics committee of the Institute. After obtaining informed consent, all individuals were personally interviewed using a predetermined questionnaire. Information on age, age of marriage, use of IUCD, oral contraception, vaginal douching, the use of condom, number of sexual partners, STD in partners, occupation, region of origin were recorded.

Table 1: Nugent scoring of Gram smears for diagnosis of bacterial vaginosis.

Statistical analysis

Descriptive statistics of patients and controls were presented as mean and SDs for continuous measures while frequencies and percentages were used for categorical measures. Differences in genotype frequencies between patients and controls were estimated by Pearson chi-square test. The risk factors associated with developing bacterial vaginosis were estimated as odds ratios (OR) with 95% confidence intervals (CI). All statistical analysis was performed using SPSS software version 15 (SPSS, Chicago, IL, USA). The tests of statistical significance were twosided and differences were taken as significant when P-value was less than 0.05. The desired power of our study was set 80%.

Results

The study population consisted of 126 cases with bacterial vaginosis and 174 controls. The mean age and standard deviation were 27.90 (4.25 and 27.92 (5.35 for bacterial vaginosis causes and controls respectively. Demographic profile of bacterial vaginosis patients and healthy controls are shown in Table 2.

Table 2: Demographic profile of bacterial vaginosis cases and healthy controls.

IUCD, Contraception and STD in partners and bacterial vaginosis

The frequency distributions of IUCD, Contraception and STD in partners are shown in Table 3. Frequency of IUCD user was found to be higher in bacterial vaginosis patients (29.4%) as compared to healthy controls (17.2.0 %) and the difference was significant (p=0. 017, OR=1. 70; 95%CI: 1.1-2.6). Use of Contraception frequency was lower in the bacterial vaginosis patients (16.6 %) as compared to healthy controls (31.61%). The frequency of an STI in partners was also higher in bacterial vaginosis patients and the difference was also significant (p=0.001, OR=8.28; 95%CI: 1.8-36.3).

Table 3: Frequency distribution of IUCD, Use of contraception and STD in partners in bacterial vaginosis cases and healthy controls.

Vaginal douching and condom and bacterial vaginosis

We analyzed the association of vaginal douching and condom with bacterial vaginosis. As shown in Table 4, the frequency of vaginal douching was higher in bacterial vaginosis patients, but the difference was not significant (p=0.20, OR=1.33, 95%CI: 0.8-2.0). The association between risk factors associated with developing bacterial vaginosis was analyzed but a low risk was observed in condom user patients.

Table 4: Frequency distribution of vaginal douching and condom in bacterial vaginosis cases and healthy controls.

Discussion

Bacterial vaginosis is a common cause of malodorous vaginal discharge in women [30]. Three million symptomatic cases are reported annually in the United States, but millions more remain unreported or unrecognized [31,32].

The present study attempts to assess the risk factors associated with bacterial vaginosis. Our study showed that individuals using an intrauterine contraceptive device (IUCD) were at significant increased risk of bacterial vaginosis (p=0.017; OR= 1.70). Since, the contribution of IUCD used to trigger vaginal flora changes that will lead to the development of bacterial vaginitis and it may have risk of bacterial vaginosis. Earlier studies have found a significant association with the IUCD user bacterial vaginosis cases than controls in populations of the UK; p = 0.04, 27% cf. 14% [33], Indonesia, USA; 47.2% and 29.9% [34], Turkey; p < 0.05 [35]. However, some previous studies showed contradictory results and found no significant difference of IUCD user bacterial vaginosis cases in the populations of India [36], United States [37] and Chile [38].

In the present study, patient using oral contraception was at protection of BV (p=0.11; OR=0.62). The estrogen increases the glycogen content of vaginal epithelial cell activity; in turn inhibiting the in vitro growth of certain bacteria, which may result in low risk for bacterial vaginosis [19]. Our findings were supported with previous studies done in population of UK [27], Sweden [39], Netherlands [40], USA [20,41,42], turkey [43].

The epidemiological profiles were consistent with trichomoniasis and bacterial vaginosis being sexually transmitted diseases [24]. In the present study, an association was observed between STI in partners and risk of bacterial vaginosis, which suggest that sexually transmitted role of bacterial vaginosis is its occurrence in virginal females and its colonization of the rectum in virginal boys and girls. More studies with larger sample size are required to confirm the influence of STI in partners on the risk of bacterial vaginosis.

Various studies have pointed out relationship between vaginal douching and modulation of risk in bacterial vaginosis in the populations of USA, Kenya and Thailand [7,41,44,45]. Our findings suggest that the effect of vaginal douching may modulate the risk of bacterial vaginosis (OR=1.33 fold) but could not reach statistical significance probably due to limited sample size of the study. Earlier studies of Onderdonk et al. [46] reported that douches containing providine-iodine had a more profound inhibitory effect on vaginal Lactobacillus than did douches containing saline or acetic acid. So, it is plausible that vaginal douching may not alter the vaginal ecology and propel vaginal organisms up through the cervical OS, and it may not be associated with risk of bacterial vaginosis. The association between vaginal douching and bacterial vaginosis is inconsistent, perhaps reflecting the heterogeneity of the techniques and substances used. Previous studies have found that no significant differences in between users and non-users of vaginal douching and did not increase risk for altered vaginal flora or BV in vaginal douche users in population of Brazil [47], USA [26], UK [27].

In this study, we also analyzed the effect of condom with low protection of the bacterial vaginosis, but found no significant association (p=0.29; OR= 1.12).We hypothesized that condom user women have not been in direct contact of vaginal epithelial cells and condom act as barrier for bacterial cytotoxins. Therefore, condom may play a role in protection of BV. Previous studies have also found that bacterial vaginosis was less prevalent among women who always used condoms during sexual intercourse and is supported by studies in populations of USA and India [41,42,48-50].

In summary, study suggests that use of IUCD and presence of STD in partners may confer higher risk for bacterial vaginosis. Vaginal douching may also influence the risk of bacterial vaginosis. Further studies in larger sample size will be required to screen the risk factors associated with bacterial vaginosis.

Acknowledgement

The study was supported by research grant from UP Council of Science and Technology (UPCST) India.

References

1. Svare JA, Schmidt H, Hansen BB, Lose G (2006) Bacterial vaginosis in a cohort of Danish pregnant women: prevalence and relationship with preterm delivery, low birthweight and perinatal infections. BJOG 113: 1419-1425.
2. Paavonen J, Teisala K, Heinonen PK, Aine R, Laine S, et al. (1987) Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynecologic 94: 454-460.
3. Hillier SL, Kiviat NB, Hawes SE, Hasselquist MB, Hanssen PW, et al. (1996) Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol 175: 435-441.
4. Bump RC, Buesching WJ 3rd (1988) Bacterial vaginosis in virginal and sexually active adolescent females: evidence against exclusive sexual transmission. Am J Obstet Gynecol 158: 935-939.
5. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, et al. (1997) HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350: 546-550.
6. Myer L, Denny L, Telerant R, Souza Md, Wright TC Jr, et al. (2005) Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis 192: 1372-1380.
7. Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, et al. (2007) The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 34: 864-869.
8. Bhalla P, Chawla R, Garg S, Singh MM, Raina U, et al. (2007) Prevalence of bacterial vaginosis among women in Delhi, India. Indian J Med Res 125: 167-172.
9. Shethwala ND, Mulla SA, Kosambiya JK, Desai VK (2009) Sexually transmitted infections and reproductive tract infections in female sex workers. Indian J Pathol Microbiol 52: 198-199.
10. Priestley CJ, Jones BM, Dhar J, Goodwin L (1997) What is normal vaginal flora? Genitourin Med 73: 23-28.
11. Eschenbach DA, Hillier S, Critchlow C, Stevens C, DeRouen T, et al. (1988) Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol 158: 819-828.
12. Goldenberg RL, Klebanoff MA, Nugent R, Krohn MA, Hillier S, et al.( 1996)Bacterial colonization of the vagina during pregnancy in four ethnic groups. Am J Obstet Gynecol 174:1618-1621.
13. Sobel JD (1990) Bacterial vaginosis. Br J Clin Pract Suppl 71: 65-69.
14. Bukusi EA, Cohen CR, Meier AS, Waiyaki PG, Nguti R, et al. (2006) Bacterial vaginosis: risk factors among Kenyan women and their male partners. Sex Transm Dis 33: 361-367.
15. Hassan WM, Lavreys L, Chohan V, Richardson BA, Mandaliya K, et al.(2007) Associations between intravaginal practices and bacterial vaginosis in Kenyan female sex workers without symptoms of vaginal infections. Sex Transm Dis 34:384-388.
16. Ness RB, Hillier SL, Richter HE, Soper DE, Stamm C, et al. (2002) Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol 100: 765.
17. Fethers KA, Fairley CK, Hocking JS, Gurrin LC, Bradshaw CS (2008) Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis. Clin Infect Dis 47: 1426-1435.
18. Cherpes TL, Hillier SL, Meyn LA, Busch JL, Krohn MA (2008) A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis 35:78-83.
19. Hillier SL, Lau RJ (1997)Vaginalmicroflora in postmenopausal women who have not received estrogen replacement therapy. Clin Infect Dis 25:S123-126.
20. Riggs M, Klebanoff M, Nansel T, Zhang J, Schwebke J, et al.(2007) Longitudinal association between hormonal contraceptives and bacterial vaginosis in women of reproductive age. Sex Transm Dis 34:954-959.
21. Hellberg D, Nilsson S, Mårdh PA (2000) Bacterial vaginosis and smoking. Int J STD AIDS 11: 603-606.
22. Nilsson U, Hellberg D, Shoubnikova M, Nilsson S, Mårdh PA (1997) Sexual behavior risk factors associated with bacterial vaginosis and Chlamydia trachomatis infection. Sex Transm Dis 24: 241-246.
23. Calzolari E, Masciangelo R, Milite V, Verteramo R (2000) Bacterial vaginosis and contraceptive methods. Int J Gynaecol Obstet 70: 341-346.
24. Hart G (1993) Factors associated with trichomoniasis, candidiasis and bacterial vaginosis. Int J STD AIDS 4: 21-25.
25. Thomason JL, Gelbart SM, Scaglione NJ (1991) Bacterial vaginosis: current review with indications for asymptomatic therapy. Am J Obstet Gynecol 165: 1210-1217.
26. Brotman RM, Ghanem KG, Klebanoff MA, Taha TE, Scharfstein DO, et al. (2008) The effect of vaginal douching cessation on bacterial vaginosis: a pilot study. Am J Obstet Gynecol 198: 628.
27. Baisley K, Changalucha J, Weiss HA, Mugeye K, Everett D, et al. (2009) Bacterial vaginosis in female facility workers in north-western Tanzania: prevalence and risk factors. Sex Transm Infect 85: 370-375.
28. Rifkin SB, Smith MR, Brotman RM, Gindi RM, Erbelding EJ (2009) Hormonal contraception and risk of bacterial vaginosis diagnosis in an observational study of women attending STD clinics in Baltimore, MD. Contraception 80: 63-67.
29. Ashraf-Ganjoei T (2005) Risk factors for bacterial vaginosis in women attending a hospital in Kerman, Islamic Republic of Iran. East Mediterr Health J 11: 410-415.
30. Rajamanoharan S, Low N, Jones SB, Pozniak AL (1999) Bacterial vaginosis, ethnicity, and the use of genital cleaning agents: a case control study. Sex Transm Dis 26: 404-409.
31. Schwebke JR (2000) Bacterial Vaginosis. Curr Infect Dis Rep 2: 14-17.
32. Fleury FJ (1981) Adult vaginitis. ClinObstetGynecol 24: 407-438.
33. Neale R, Knight I, Keane F (2009) Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device? 20:423-424.
34. Joesoef MR, Karundeng A, Runtupalit C, Moran JS, Lewis JS, et al. (2001) High rate of bacterial vaginosis among women with intrauterine devices in Manado, Indonesia. Contraception 64: 169-172.
35. Demirezen S, Küçük A, Beksaç MS (2006) The association between copper containing IUCD and bacterial vaginosis. Cent Eur J Public Health 14: 138-140.
36. Agarwal K, Sharma U, Acharya V (2004) Microbial and cytopathological study of intrauterine contraceptive device users. Indian J Med Sci 58: 394-399.
37. Go VF, Quan VM, Celentano DD, Moulton LH, Zenilman JM (2006) Prevalence and risk factors for reproductive tract infections among women in rural Vietnam. Southeast Asian J Trop Med Public Health 37: 185-189.
38. Meirik O (2007) Intrauterine devices - upper and lower genital tract infections. Contraception 75: S41-47.
39. Shoubnikova M, Hellberg D, Nilsson S, Mårdh PA (1997) Contraceptive use in women with bacterial vaginosis. Contraception 55: 355-358.
40. van de Wijgert JH, Morrison CS, Cornelisse PG, Munjoma M, Moncada J, et al. (2008) Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune DeficSyndr 48: 203-210.
41. Holzman C, Leventhal JM, Qiu H, Jones NM, Wang J; BV Study Group (2001) Factors linked to bacterial vaginosis in nonpregnant women. Am J Public Health 91: 1664-1670.
42. Baeten JM, Nyange PM, Richardson BA, Lavreys L, Chohan B, et al. (2001) Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol 185: 380-385.
43. Ocak S, Cetin M, Hakverdi S, Dolapcioglu K, Gungoren A, et al. (2007) Effects of intrauterine device and oral contraceptive on vaginal flora and epithelium. Saudi Med J 28: 727-731.
44. Fonck K, Kaul R, Keli F, Bwayo JJ, Ngugi EN, et al. (2001) Sexually transmitted infections and vaginal douching in a population of female sex workers in Nairobi, Kenya. Sex Transm Infect 77: 271-275.
45. Watcharotone W, Sirimai K, Kiriwat O, Nukoolkarn P, Watcharaprapapong O, et al. (2004) Prevalence of bacterial vaginosis in Thai women attending the family planning clinic, Siriraj Hospital. J Med Assoc Thai 87: 1419-1424.
46. Onderdonk AB, Delaney ML, Hinkson PL, DuBois AM (1992) Quantitative and qualitative effects of douche preparations on vaginal microflora. ObstetGynecol 80: 333-338.
47. Amaral R, Giraldo PC, Gonçalves AK, Junior JE, Santos-Pereira S, et al. (2007) Evaluation of hygienic douching on the vaginal microflora of female sex workers. Int J STD AIDS 18: 770-773.
48. Yotebieng M, Turner AN, Hoke TH, Van Damme K, Rasolofomanana JR, et al. (2009) Effect of consistent condom use on 6-month prevalence of bacterial vaginosis varies by baseline BV status. Trop Med Int Health 14: 480-486.
49. Hutchinson KB, Kip KE, Ness RB (2007) Condom use and its association with bacterial vaginosis and bacterial vaginosis-associated vaginal microflora. Epidemiology 18: 702-708.
50. Thulkar J, Kriplani A, Agarwal N, Vishnubhatla S (2010) Aetiology& risk factors of recurrent vaginitis & its association with various contraceptive methods. Indian J Med Res 131: 83-87.